Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000094

Chief Medical Officer sold 14,474 shares at an average $24.19 ($350,087)

  • Chief Medical Officer acquired 8,126 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Rodman David Malcom Chief Medical Officer 2026-06-15 Option exercise 10b5-1 +3,542 $10.20 $36,128 66,985 D
Rodman David Malcom Chief Medical Officer 2026-06-15 Sale 10b5-1 −9,890 $23.81 $235,487 57,095 D
Rodman David Malcom Chief Medical Officer 2026-06-17 Option exercise 10b5-1 +4,167 $14.25 $59,380 61,262 D
Rodman David Malcom Chief Medical Officer 2026-06-17 Option exercise 10b5-1 +417 $15.44 $6,438 61,679 D
Rodman David Malcom Chief Medical Officer 2026-06-17 Sale 10b5-1 −4,584 $25.00 $114,600 57,095 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-06-15 Option exercise · Stock Option 10b5-1 −3,542 113,334 D
Rodman David Malcom Chief Medical Officer 2026-06-17 Option exercise · Stock Option 10b5-1 −4,167 83,334 D
Rodman David Malcom Chief Medical Officer 2026-06-17 Option exercise · Stock Option 10b5-1 −417 3,750 D
Open-market sales · 14,474 sh · avg $24.19 · $350,087
Loading xslF345X06/wk-form4_1781745485.xml…